Plasmacytoma of the iliac bone in a seven- year-old girl: A rare tumor with no to ignore

Franck, Lohourou Grah; Bertrand, Kpangni Ahua Jean; Célestin, Bénie Abdous; Ibrahim, Traoré; Ibrahiman, Touré; Constance, Bony; Cinthia, N’Da-Koffi

doi:10.1016/j.epsc.2020.101582

Cited by 1 publication

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Solitary bone plasmacytoma (SBP) is a rare oncologic disease, corresponding to less than 5% of plasma cells malignant tumors (Kilciksiz et al, 2012;Serin & Hilmi Dogu, 2020). It is characterized as an aggressive localized tumor caused by the accumulation of neoplastic monoclonal plasma cells, found mostly in adults presenting about 55 years (Franck et al, 2021;Kilciksiz et al, 2012). However, in order to define SBP criteria, only a single bone area must be affected, without evidence of systemic disease (Say et al, 2014;Serin & Hilmi Dogu, 2020).…”

Section: Introductionmentioning

confidence: 99%

Exploring Solitary Bone Plasmacytoma: A Rare Case Report

Pucca¹,

Brito-Souza²,

Alexandre-Silva³

et al. 2021

IJCCR

View full text Add to dashboard Cite

The Solitary Bone Plasmacytoma (SBP) is a rare oncologic disease corresponding to less than 5% of the malignant neoplasms of the plasma cells. It is characterized as a localized aggressive tumor consequent to the accumulation of monoclonal plasma cell neoplasms and, due to the rarity of the disease, there are only few clinical studies reporting it especially regarding prognostic factors and treatment. Here, we report a fatal clinical case of SPB in Roraima, the northernmost state of Brazil. The study shows a case of solitary bone plasmacytoma on the femur, where the patient was submitted to the preconized radiotherapy cycles. However, over approximately four-years following the diagnose, the patient required multi-modal approach to guarantee quality of life during the survival time. Finally, this study explores SBP-related issues and examines the challenges physicians face when managing the care of patients with SBP.

show abstract